Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2019
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
David M Cordas Dos Santos, Rima M Saliba, Romil Patel, et al.
Blood
|
April 16, 2008
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F Khouri, Peter McLaughlin, Rima M Saliba, et al.
Cancer
|
June 17, 2021
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis
Koji Sasaki, Hagop M Kantarjian, Kiyomi Morita, et al.
Bone Marrow Transplantation
|
January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD
Rohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
American Journal of Hematology
|
February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant
Issa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Acta Haematologica
|
July 1, 2020
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia
Amanda L Olson, Rima M Saliba, Betul Oran, et al.
Blood
|
May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results
Issa F Khouri, Rima M Saliba, William D Erwin, et al.
Blood Advances
|
September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography
Chelsea C Pinnix, Bouthaina Dabaja, Mohamed Amin Ahmed, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 2, 2019
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation
David M Cordas Dos Santos, Rima M Saliba, Romil Patel, et al.
Blood
|
April 16, 2008
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
Issa F Khouri, Peter McLaughlin, Rima M Saliba, et al.
Cancer
|
June 17, 2021
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis
Koji Sasaki, Hagop M Kantarjian, Kiyomi Morita, et al.
Bone Marrow Transplantation
|
January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD
Rohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
American Journal of Hematology
|
February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
Issa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant
Issa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Acta Haematologica
|
July 1, 2020
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia
Amanda L Olson, Rima M Saliba, Betul Oran, et al.
Blood
|
May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results
Issa F Khouri, Rima M Saliba, William D Erwin, et al.
Blood Advances
|
September 13, 2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
Stefan O Ciurea, Maria Cecilia Borges Bittencourt, Denái R Milton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2015
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography
Chelsea C Pinnix, Bouthaina Dabaja, Mohamed Amin Ahmed, et al.
Page
of 7